Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Seung Woo Chung

Showing results (11-20 of 43) with videos related to

Pageof 5
Sort By:
Anti-Cancer Drugs|July 9, 2014
Combinational chemoprevention effect of celecoxib and an oral antiangiogenic LHD4 on colorectal carcinogenesis in miceJi-young Kim, Farzana Alam, Seung Woo Chung, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|December 20, 2014
Antiangiogenic and anticancer effect of an orally active low molecular weight heparin conjugates and its application to lung cancer chemopreventionJi-young Kim, Taslim A Al-Hilal, Seung Woo Chung, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|April 21, 2022
Caspase-3 mediated switch therapy of self-triggered and long-acting prodrugs for metastatic TNBCHa Rin Kim, Young Seok Cho, Seung Woo Chung, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|January 20, 2019
The novel strategy for concurrent chemoradiotherapy by conjugating the apoptotic cell-binding moiety to caspase-3 activated doxorubicin prodrugYoung Seok Cho, Seung Woo Chung, Ha Rin Kim, et al.
Biomaterials|December 19, 2012
An apoptosis-homing peptide-conjugated low molecular weight heparin-taurocholate conjugate with antitumor propertiesSang Mun Bae, Jong-Ho Kim, Seung Woo Chung, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|December 3, 2014
Functionalized heparin-protamine based self-assembled nanocomplex for efficient anti-angiogenic therapyFarzana Alam, Taslim A Al-Hilal, Seung Woo Chung, et al.
Biomaterials|June 7, 2017
A heparin conjugate, LHbisD4, inhibits lymphangiogenesis and attenuates lymph node metastasis by blocking VEGF-C signaling pathwayJeong Uk Choi, Seung Woo Chung, Taslim A Al-Hilal, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|October 16, 2012
Cyclic RGDyk-conjugated LMWH-taurocholate derivative as a targeting angiogenesis inhibitorAsarasin Adulnirath, Seung Woo Chung, Jooho Park, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|January 18, 2017
Metronomic chemotherapy using orally active carboplatin/deoxycholate complex to maintain drug concentration within a tolerable range for effective cancer managementFoyez Mahmud, Seung Woo Chung, Farzana Alam, et al.
Biomaterials|April 17, 2016
Albumin-binding caspase-cleavable prodrug that is selectively activated in radiation exposed local tumorSeung Woo Chung, Jeong Uk Choi, Beom Seok Lee, et al.
Pageof 5

Showing results (11-20 of 43) with videos related to

Sort By:
Pageof 5
Anti-Cancer Drugs|July 9, 2014
Combinational chemoprevention effect of celecoxib and an oral antiangiogenic LHD4 on colorectal carcinogenesis in miceJi-young Kim, Farzana Alam, Seung Woo Chung, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|December 20, 2014
Antiangiogenic and anticancer effect of an orally active low molecular weight heparin conjugates and its application to lung cancer chemopreventionJi-young Kim, Taslim A Al-Hilal, Seung Woo Chung, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|April 21, 2022
Caspase-3 mediated switch therapy of self-triggered and long-acting prodrugs for metastatic TNBCHa Rin Kim, Young Seok Cho, Seung Woo Chung, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|January 20, 2019
The novel strategy for concurrent chemoradiotherapy by conjugating the apoptotic cell-binding moiety to caspase-3 activated doxorubicin prodrugYoung Seok Cho, Seung Woo Chung, Ha Rin Kim, et al.
Biomaterials|December 19, 2012
An apoptosis-homing peptide-conjugated low molecular weight heparin-taurocholate conjugate with antitumor propertiesSang Mun Bae, Jong-Ho Kim, Seung Woo Chung, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|December 3, 2014
Functionalized heparin-protamine based self-assembled nanocomplex for efficient anti-angiogenic therapyFarzana Alam, Taslim A Al-Hilal, Seung Woo Chung, et al.
Biomaterials|June 7, 2017
A heparin conjugate, LHbisD4, inhibits lymphangiogenesis and attenuates lymph node metastasis by blocking VEGF-C signaling pathwayJeong Uk Choi, Seung Woo Chung, Taslim A Al-Hilal, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|October 16, 2012
Cyclic RGDyk-conjugated LMWH-taurocholate derivative as a targeting angiogenesis inhibitorAsarasin Adulnirath, Seung Woo Chung, Jooho Park, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|January 18, 2017
Metronomic chemotherapy using orally active carboplatin/deoxycholate complex to maintain drug concentration within a tolerable range for effective cancer managementFoyez Mahmud, Seung Woo Chung, Farzana Alam, et al.
Biomaterials|April 17, 2016
Albumin-binding caspase-cleavable prodrug that is selectively activated in radiation exposed local tumorSeung Woo Chung, Jeong Uk Choi, Beom Seok Lee, et al.
Pageof 5